Sukanthi Kovvuru
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: University of Arkansas Medical Center (2018–2022); Yale University (2020); Baptist Health Foundation (2020–2021)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Sukanthi Kovvuru's research focuses on the neurological and neuropsychiatric manifestations of COVID-19, as well as the impact of the pandemic on individuals with pre-existing neurological conditions. Her work investigates the clinical characteristics of various neurological disorders, including those related to fibroblast growth factor receptor 3 antibodies and cerebral venous sinus thrombosis associated with SARS-CoV-2 infection.
Kovvuru also examines the effects of COVID-19 on patients with conditions such as myasthenia gravis and prior ischemic stroke, exploring how the pandemic influences treatment and outcomes. Additionally, her research extends to medical education, specifically evaluating the effectiveness of virtual learning methods for resident education in electroencephalogram interpretation during the COVID-19 pandemic. Her scholarship metrics include an h-index of 9, with 24 publications and 413 total citations.
Metrics
- h-index: 9
- Publications: 24
- Citations: 413
Selected Publications
-
DNL343 and Disease Progression in Amyotrophic Lateral Sclerosis (2026)
-
COVID-19 in patients with neurological disorders (4518) (2021)
-
Trends in Demographics of Neurology House Staff in the United States (2021)
-
Neuropsychiatric Manifestations in COVID - 19 (1282) (2021)
-
Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke (5057) (2021)
-
Impact of cerebral venous sinus thrombosis associated with COVID-19 (2021)
-
Electronic health record derived-impact of COVID-19 on myasthenia gravis (2021)
-
Chronic Autoimmune Neurological Disorders and Immunosuppression During the COVID-19 Pandemic (2020)
-
Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic (2020)
-
Resident Education During COVID-19 Pandemic: Effectiveness of Virtual Electroencephalogram Learning (2020)
-
Risk of coronavirus disease 2019 (COVID-19) from hospital admission during the pandemic (2020)
-
Biologics in systemic autoimmune diseases during COVID-19 pandemic (2020)
-
Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke (2020)
-
COVID-19 in patients with neurological disorders (2020)
-
A neuromuscular‐based analysis of the open payments program (2020)
Collaboration Network
Top Collaborators
- Spectrum of neuropsychiatric manifestations in COVID-19
- Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic
- Electronic health record derived-impact of COVID-19 on myasthenia gravis
- Resident Education During COVID-19 Pandemic: Effectiveness of Virtual Electroencephalogram Learning
- Impact of cerebral venous sinus thrombosis associated with COVID-19
Showing 5 of 17 shared publications
- Spectrum of neuropsychiatric manifestations in COVID-19
- Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic
- Electronic health record derived-impact of COVID-19 on myasthenia gravis
- Resident Education During COVID-19 Pandemic: Effectiveness of Virtual Electroencephalogram Learning
- Impact of cerebral venous sinus thrombosis associated with COVID-19
Showing 5 of 16 shared publications
- Spectrum of neuropsychiatric manifestations in COVID-19
- Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic
- Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke
- Trends in Demographics of Neurology House Staff in the United States
- Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke (5057)
Showing 5 of 9 shared publications
- Spectrum of neuropsychiatric manifestations in COVID-19
- Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic
- Resident Education During COVID-19 Pandemic: Effectiveness of Virtual Electroencephalogram Learning
- Why are acute ischemic stroke patients not receiving thrombolysis in a telestroke network?
- A neuromuscular‐based analysis of the open payments program
Showing 5 of 8 shared publications
- Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic
- Electronic health record derived-impact of COVID-19 on myasthenia gravis
- Clinical characteristics of fibroblast growth factor receptor 3 antibody‐related polyneuropathy: a retrospective study
- Risk of coronavirus disease 2019 (COVID-19) from hospital admission during the pandemic
- Reply to: What is the pattern of the neuropathy associated with anti‐FGFR3 antibodies?
Showing 5 of 8 shared publications
- Spectrum of neuropsychiatric manifestations in COVID-19
- Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic
- Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke
- A neuromuscular‐based analysis of the open payments program
- Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke (5057)
Showing 5 of 8 shared publications
- Spectrum of neuropsychiatric manifestations in COVID-19
- Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke
- Biologics in systemic autoimmune diseases during COVID-19 pandemic
- Risk of coronavirus disease 2019 (COVID-19) from hospital admission during the pandemic
- Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke (5057)
Showing 5 of 8 shared publications
- Spectrum of neuropsychiatric manifestations in COVID-19
- Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic
- Resident Education During COVID-19 Pandemic: Effectiveness of Virtual Electroencephalogram Learning
- A neuromuscular‐based analysis of the open payments program
- Trends in Demographics of Neurology House Staff in the United States
Showing 5 of 7 shared publications
- Spectrum of neuropsychiatric manifestations in COVID-19
- Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic
- Why are acute ischemic stroke patients not receiving thrombolysis in a telestroke network?
- Biologics in systemic autoimmune diseases during COVID-19 pandemic
- Chronic Autoimmune Neurological Disorders and Immunosuppression During the COVID-19 Pandemic
Showing 5 of 6 shared publications
- Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke
- Why are acute ischemic stroke patients not receiving thrombolysis in a telestroke network?
- Biologics in systemic autoimmune diseases during COVID-19 pandemic
- A neuromuscular‐based analysis of the open payments program
- Trends in Demographics of Neurology House Staff in the United States
Showing 5 of 6 shared publications
- Spectrum of neuropsychiatric manifestations in COVID-19
- Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic
- Resident Education During COVID-19 Pandemic: Effectiveness of Virtual Electroencephalogram Learning
- A neuromuscular‐based analysis of the open payments program
- Chronic Autoimmune Neurological Disorders and Immunosuppression During the COVID-19 Pandemic
Showing 5 of 6 shared publications
- Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic
- Electronic health record derived-impact of COVID-19 on myasthenia gravis
- Clinical characteristics of fibroblast growth factor receptor 3 antibody‐related polyneuropathy: a retrospective study
- Reply to: What is the pattern of the neuropathy associated with anti‐FGFR3 antibodies?
- Chronic Autoimmune Neurological Disorders and Immunosuppression During the COVID-19 Pandemic
- Spectrum of neuropsychiatric manifestations in COVID-19
- Why are acute ischemic stroke patients not receiving thrombolysis in a telestroke network?
- Neuropsychiatric Manifestations in COVID - 19 (1282)
- Abstract WP72: Why Are Acute Ischemic Stroke Patients Not Receiving IV tPA in Telestroke Network
- Spectrum of neuropsychiatric manifestations in COVID-19
- Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke
- A neuromuscular‐based analysis of the open payments program
- Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke (5057)
- A neuromuscular‐based analysis of the open payments program
- Trends in Demographics of Neurology House Staff in the United States
- Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke (5057)
- COVID-19 in patients with neurological disorders (4518)
Similar Researchers
Based on overlapping research topics